Mark Kelly, NASA (IMAGE)

NASA/Johnson Space Center

Mark Kelly, NASA

Caption

Antibiotic Effectiveness in Space (AES-1) consists of Commercial Generic Bioprocessing Apparatus and 16 Group Activation Packs. Here, astronaut Mark Kelly works with similar hardware used in the NLP-Vaccine-10 investigation.

Credit

BioServe Space Technologies

Usage Restrictions

Image Credit: BioServe Space Technologies

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.